Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Hartless 1
help their mental condition. After shadowing with the PT for a couple of days, I realized that the
patients are learning other ways to cope with certain things, whether it is mania or others,
through physical activities. For example: one patient suffers from mania and when she is manic
the PT will ask her to concentrate on one task such as moving her legs in a certain way, this in
turn calms her down a little. The PT also mentioned that sometimes the patients will open up to
her more because they see her as an escape from the ward and more freedom.
The experience I had with the PT, mixed with the experience of watching how the teams
treat the patients for their condition, makes me think about more effective ways of treatment in
correlation with the medications. Thinking about this through the brain of the future counselor, I
feel like the Hospital could use more one on one therapy. While they do group therapy, I think
there is high quality in helping someone through just talking to them. Once again, I mean this in
correlation with medication because some disorders such as Schizoaffective Disorder and
Bipolar Disorder are more chemical.
predictors of treatment response from first episodes (Delbert G. Robinson, Woerner, M.G.,
Alvir, J. M.J., Geisler, S., Koreen, A., Sheitman, B., Chakos, M., Mayerhoff, D., Bilder, R.,
Goldman, R., & Lieberman, J. A, 1999, pg. 544). Their method was to put them on a series of
medications progressing from one phase of the algorithm to the next until they responded
(Delbert, et. al. 1999, pg. 545) and later performed a multivariate analysis. This study found that
Although attention may not change with conventional antipsychotic treatment, [the] data
suggest that baseline attention (assessed in a different manner) predicts positive symptom
improvement in first-episode patients (Delbert, et. al. 1999, pg. 548).
Lastly, studies are being done to see what a better medication is for Schizoaffective
Disorder. In a study conducted by PV Tran, GD Tollefson, TM Sanger, Y Lu, PH Berg and CM
Beasley, Jr, two new medications were put against each other: olanzapine and haloperidol. The
study consisted of about 300 patients who met the DSM-III criteria (PV Tran, GD Tollefson,
TM Sanger, Y Lu, PH Berg and CM Beasley, Jr, 1999, pg. 15). The study was a double blind
study and each patient began with 5 mg/day; after a seven day period, the dose could be
increased or decreased by 5 mg (PV Tran, et. al., 1999, pg. 15). The researchers found that, after
many statistical tests, olanzapine outperformed haloperidol and that ...olanzapine represents an
important alternative treatment option in schizoaffective disorder (PV Tran, et. al., 1999, pg.
21).
Manic Episode, Mixed Episode and Hypomanic Episode. These episodes must not derive from
some other circumstance or illness that would logically, or better, account for its expression.
(www.jbrf.org). Within Bipolar Disorder there are two different sub groups, Bipolar 1 and
Bipolar 2. The differences in these are between full mania (7 days) and hypomania (4 days)
(www.jbrf.org).
Bipolar Disorder is also caused by chemical imbalances in the brain and has a high
genetic determination (Robert L. Leahy, 2007, pg. 419). It is commonly paired with another
disorder in the patient and many bipolar patients not only lack insight into their mania but often
have poor recollections of their manic episodes (Robert L. Leahy, 2007, pg. 419). The
researcher states that while the clinician should be treating the specific episode [they should
also be]... laying the groundwork for maintenance treatment over the long term (Robert L.
Leahy, 2007, pg. 420).
Another article goes into the treatment of Bipolar Disorder. The article, written by John R
Geddes and Miklowitz, D.J. in 2013, states several medications such as: lithium and olanzapine
are the best medications to use. They go further to state that emphasis has been put on
conducting pharmacotherapy with targeted psychotherapy...Psychological approaches build on
evidence that psychosocial stressors, including excessive family discord or distress, negative life
events, or events that disrupt sleep and wake rhythms or accelerate goal attainment are associated
with relapses and worsening symptomatic states (John R Geddes and Miklowitz, D.J., 2013).
They also go on to mention other types of therapy, such as: Group psychoeducation,
Interpersonal and social rhythm therapy, Cognitive-behavioral therapy, Family focused therapy,
and more.
experience at the hospital because it helped me learn the differences between certain disorders
from seeing them and it helped me learn to recognize one and that many are very similar.
References
Delbert G. Robinson, Woerner, M.G., Alvir, J. M.J., Geisler, S., Koreen, A., Sheitman, B.,
Chakos, M., Mayerhoff, D., Bilder, R., Goldman, R., & Lieberman, J. A. (1999). Predictors of
Treatment Response From a First Episode of Schizophrenia or Schizoaffective Disorder. Am J
Psychiatry, 156 (4), 544-549. Retrieved from
http://ajp.psychiatryonline.org/doi/pdf/10.1176/ajp.156.4.544
Delbert G. Robinson, Woerner, M. G., McMeniman, M., Mendelowitz, A., Bilder, R. M. ( 2004).
Symptomatic and Functional Recovery From a First Episode of Schizophrenia or Schizoaffective
Disorder. Am J Psychiatry, 161, 473479 Retreived from
http://ils.unc.edu/bmh/neoref/nrschizophrenia/jsp/review/tmp/393.pdf
Diagnosis by the DSM. http://www.jbrf.org/diagnosis-by-the-dsm/
John R Geddes and Miklowitz, D.J. (2013).Treatment of bipolar disorder. US National Library
of Medicine National Institutes of Health. Retrieved from
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876031/
NL Johnston-Wilson, Sims, C.D., Hofmann, J-P., Anderson, L., Shore, A.D., Torrey, E.F.,
Yolken, R.H., & the Stanley Neuropathology Consortium. (2000). Disease-specific
alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major
depressive disorder. Molecular Psychiatry, 5, 142149. Retrieved from
http://www.plasmaproteome.org/Bios_and_bibliographies/PDF's/Disease-specific
%20alterations%20in%20frontal%20cortex%20brain%20proteins%20in
%20schizophrenia%20bipolar-Johnston-Wilson-2000-Mol%20Psychiatry.pdf
Paul Lichtenstein, PhD , Yip B. H. , MSc, Bjrk, C. , MSc, Pawitan Y., PhD, Cannon T.D, PhD,
Sullivan P. F, MD, Hultman C.M, PhD. (2009). Common genetic determinants of
schizophrenia and bipolar disorder in Swedish families: a population-based study. The
Lancet, 373 (9659: 17-23): 234239. Retrieved from
http://www.sciencedirect.com/science/article/pii/S0140673609600726
PV Tran, Tollefson, G.D., Sanger, T.M., Lu,Y., Berg, P.H., & Beasley, Jr. C.M. (1999).
Olanzapine versus haloperidol in the treatment of schizoaffective disorder. Acute and
long-term therapy.The British Journal of Psychiatry, 174, 15-22. Retrieved from
https://www.researchgate.net/profile/Todd_Sanger/publication/13087485_Olanzapine_ve
rsus_haloperidol_in_the_treatment_of_schizoaffective_disorder._Acute_and_longterm_therapy/links/0fcfd511079cd312b1000000.pdf
Robert L. Leahy. (2007) Bipolar Disorder: Causes, Contexts, and Treatments. Journal of Clinical
Psychology, 63 (5), 417424. Retrieved from
https://www.researchgate.net/profile/Robert_Leahy/publication/6404413_Bipolar_disord
er_Causes_contexts_and_treatments/links/54cf9baa0cf29ca810ff4366.pdf
Thomas E. Smith, Hull, J. W., Israel, L. M., & Willson, D. R. (2000). Insight, Symptoms, and
Neurocognition in Schizophrenia and Schizoaffective Disorder. Schizophrenia Bulletin,
26 (1), 193-200. Retrieved from
http://schizophreniabulletin.oxfordjournals.org/content/26/1/193.full.pdf
What is Schizoaffective Disorder? http://www.janssencns.com/invega/schizoaffectivedisorder/about/about-schizoaffective-disorder/definition